Susceptibility of human lymphoid tissue cultured ex vivo to xenotropic murine leukemia virus-related virus (XMRV) infection

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Curriu, Marta ^a   Carrillo, Jorge ^a   Massanella, Marta ^a   Garcia, Elisabet ^a   Cunyat, Francesc ^a   Peña, Ruth ^a   Wienberg, Peter ^b   Carrato, Cristina ^c   Areal, Joan ^c   Bofill, Margarita ^a,d   Clotet, Bonaventura ^a,c   Blanco, Julià ^a   Cabrera, Cecilia ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^d INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; RALTEGRAVIR; ZIDOVUDINE; VIRUS DNA; VIRUS RNA;

ANTIVIRAL RESISTANCE; ARTICLE; B LYMPHOCYTE; EX VIVO STUDY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INFECTION SENSITIVITY; NONHUMAN; RETROVIRUS INFECTION; SUPERNATANT; T LYMPHOCYTE; TISSUE CULTURE; TONSIL; VIRUS REPLICATION; XENOTROPIC MULV RELATED VIRUS; CHEMISTRY; CYTOLOGY; LYMPHOID TISSUE; MALE; METABOLISM; PALATINE TONSIL; PROSTATE TUMOR; SECRETION; TUMOR CELL LINE; VIROLOGY;

ANIMALIA; MURINE LEUKEMIA VIRUS; XENOTROPIC MURINE LEUKEMIA VIRUS;

CELL LINE, TUMOR; CHEMOKINES; DNA, VIRAL; HUMANS; LYMPHOID TISSUE; MALE; PALATINE TONSIL; PROSTATIC NEOPLASMS; RETROVIRIDAE INFECTIONS; RNA, VIRAL; VIRUS REPLICATION; XENOTROPIC MURINE LEUKEMIA VIRUS-RELATED VIRUS;

EID: 84861204818     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037415     Document Type: Article

References (103)

1. Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, et al. (2006) Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2: e25.
2. Danielson BP, Ayala GE, Kimata JT, (2010) Detection of xenotropic murine leukemia virus-related virus in normal and tumor tissue of patients from the southern United States with prostate cancer is dependent on specific polymerase chain reaction conditions. J Infect Dis 202: 1470-1477.
3. Schlaberg R, Choe DJ, Brown KR, Thaker HM, Singh IR, (2009) XMRV is present in malignant prostatic epithelium and is associated with prostate cancer, especially high-grade tumors. Proc Natl Acad Sci U S A 106: 16351-16356.
4. Kim S, Kim N, Dong B, Boren D, Lee SA, et al. (2008) Integration site preference of xenotropic murine leukemia virus-related virus, a new human retrovirus associated with prostate cancer. J Virol 82: 9964-9977.
5. Arnold RS, Makarova NV, Osunkoya AO, Suppiah S, Scott TA, et al. (2010) XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH. Urology 75: 755-761.
6. Hong S, Klein EA, Das Gupta J, Hanke K, Weight CJ, et al. (2009) Fibrils of prostatic acid phosphatase fragments boost infections with XMRV (xenotropic murine leukemia virus-related virus), a human retrovirus associated with prostate cancer. J Virol 83: 6995-7003.
7. Dong B, Kim S, Hong S, Das Gupta J, Malathi K, et al. (2007) An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci U S A 104: 1655-1660.
8. Fischer N, Hellwinkel O, Schulz C, Chun FK, Huland H, et al. (2008) Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer. J Clin Virol 43: 277-283.
9. Switzer WM, Jia H, Zheng H, Tang S, Heneine W, (2011) No association of xenotropic murine leukemia virus-related viruses with prostate cancer. PLoS One 6: e19065.
10. Verhaegh GW, de Jong AS, Smit FP, Jannink SA, Melchers WJ, et al. (2011) Prevalence of human xenotropic murine leukemia virus-related gammaretrovirus (XMRV) in Dutch prostate cancer patients. Prostate 71: 415-420.
11. Barnes E, Flanagan P, Brown A, Robinson N, Brown H, et al. (2010) Failure to detect xenotropic murine leukemia virus-related virus in blood of individuals at high risk of blood-borne viral infections. J Infect Dis 202: 1482-1485.
12. Hohn O, Krause H, Barbarotto P, Niederstadt L, Beimforde N, et al. (2009) Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients. Retrovirology 6: 92.
13. Sfanos KS, Sauvageot J, Fedor HL, Dick JD, De Marzo AM, et al. (2008) A molecular analysis of prokaryotic and viral DNA sequences in prostate tissue from patients with prostate cancer indicates the presence of multiple and diverse microorganisms. Prostate 68: 306-320.
14. Sabunciyan S, Mandelberg N, Rabkin CS, Yolken R, Viscidi R, (2011) No difference in antibody titers against xenotropic MLV related virus in prostate cancer cases and cancer-free controls. Mol Cell Probes 25: 134-136.
15. Akgul B, Pfister D, Knuchel R, Heidenreich A, Wieland U, et al. (2011) No evidence for a role of xenotropic murine leukaemia virus-related virus and BK virus in prostate cancer of German patients. Med Microbiol Immunol.
16. Cool M, Bouchard N, Masse G, Laganiere B, Dumont A, et al. (2011) No detectable XMRV in subjects with chronic fatigue syndrome from Quebec. Virology.
17. Stieler K, Schindler S, Schlomm T, Hohn O, Bannert N, et al. (2011) No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern Europe. PLoS One 6: e25592.
18. Martinez-Fierro ML, Leach RJ, Gomez-Guerra LS, Garza-Guajardo R, Johnson-Pais T, et al. (2010) Identification of viral infections in the prostate and evaluation of their association with cancer. BMC Cancer 10: 326.
19. Aloia AL, Sfanos KS, Isaacs WB, Zheng Q, Maldarelli F, et al. (2010) XMRV: a new virus in prostate cancer? Cancer Res 70: 10028-10033.
20. Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, et al. (2009) Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 326: 585-589.
21. Fischer N, Schulz C, Stieler K, Hohn O, Lange C, et al. (2010) Xenotropic murine leukemia virus-related gammaretrovirus in respiratory tract. Emerg Infect Dis 16: 1000-1002.
22. Lo SC, Pripuzova N, Li B, Komaroff AL, Hung GC, et al. (2010) Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proc Natl Acad Sci U S A 107: 15874-15879.
23. Erlwein O, Kaye S, McClure MO, Weber J, Wills G, et al. (2010) Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS One 5: e8519.
24. Groom HC, Boucherit VC, Makinson K, Randal E, Baptista S, et al. (2010) Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology 7: 10.
25. Henrich TJ, Li JZ, Felsenstein D, Kotton CN, Plenge RM, et al. (2010) Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions. J Infect Dis 202: 1478-1481.
26. Switzer WM, Jia H, Hohn O, Zheng H, Tang S, et al. (2010) Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States. Retrovirology 7: 57.
27. Shin CH, Bateman L, Schlaberg R, Bunker AM, Leonard CJ, et al. (2011) Absence of XMRV and other MLV-related viruses in patients with Chronic Fatigue Syndrome. J Virol.
28. Satterfield BC, Garcia RA, Jia H, Tang S, Zheng H, et al. (2011) Serologic and PCR testing of persons with chronic fatigue syndrome in the United States shows no association with xenotropic or polytropic murine leukemia virus-related viruses. Retrovirology 8: 12.
29. Hong P, Li J, Li Y, (2010) Failure to detect Xenotropic murine leukaemia virus-related virus in Chinese patients with chronic fatigue syndrome. Virol J 7: 224.
30. Mi Z, Lu Y, Zhang S, An X, Wang X, et al. (2011) Absence of xenotropic murine leukemia virus-related virus in blood donors in China. Transfusion.
31. Knox K, Carrigan D, Simmons G, Teque F, Zhou Y, et al. (2011) No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected. Science 333: 94-97.
32. Alberts B, (2011) Editorial Expression of Concern. Science.
33. Silverman RH, Das Gupta J, Lombardi VC, Ruscetti FW, Pfost MA, et al. (2011) Partial retraction. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 334: 176.
34. Alberts B, (2011) Retraction. Science 334: 1636.
35. Lo SC, Pripuzova N, Li B, Komaroff AL, Hung GC, et al. (2012) Retraction for Lo et al., Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proc Natl Acad Sci U S A 109: 346.
36. Hue S, Gray ER, Gall A, Katzourakis A, Tan CP, et al. (2010) Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology 7: 111.
37. Oakes B, Tai AK, Cingoz O, Henefield MH, Levine S, et al. (2010) Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences. Retrovirology 7: 109.
38. Robinson MJ, Erlwein OW, Kaye S, Weber J, Cingoz O, et al. (2010) Mouse DNA contamination in human tissue tested for XMRV. Retrovirology 7: 108.
39. Sato E, Furuta RA, Miyazawa T, (2010) An endogenous murine leukemia viral genome contaminant in a commercial RT-PCR kit is amplified using standard primers for XMRV. Retrovirology 7: 110.
40. Smith RA, (2010) Contamination of clinical specimens with MLV-encoding nucleic acids: implications for XMRV and other candidate human retroviruses. Retrovirology 7: 112.
41. Katzourakis A, Hue S, Kellam P, Towers GJ, (2011) Phylogenetic analysis of MLV sequences from longitudinally sampled Chronic Fatigue Syndrome patients suggests PCR contamination rather than viral evolution. J Virol.
42. Wolff D, Gerritzen A, (2011) Presence of murine leukemia virus (MLV)-related virus gene sequences in a commercial RT-PCR reagent. Clin Lab 57: 631-634.
43. Erlwein O, Robinson MJ, Dustan S, Weber J, Kaye S, et al. (2011) DNA extraction columns contaminated with murine sequences. PLoS One 6: e23484.
44. Tuke PW, Tettmar KI, Tamuri A, Stoye JP, Tedder RS, (2011) PCR master mixes harbour murine DNA sequences. Caveat emptor! PLoS One 6: e19953.
45. Garson JA, Kellam P, Towers GJ, (2011) Analysis of XMRV integration sites from human prostate cancer tissues suggests PCR contamination rather than genuine human infection. Retrovirology 8: 13.
46. Rusmevichientong A, Das Gupta J, Elias PS, Silverman RH, Chow SA, (2011) Analysis of single-nucleotide polymorphisms in patient-derived retrovirus integration sites reveals contamination from cell lines acutely infected by xenotropic murine leukemia virus-related virus. J Virol 85: 12830-12834.
47. Paprotka T, Delviks-Frankenberry KA, Cingoz O, Martinez A, Kung HJ, et al. (2011) Recombinant Origin of the Retrovirus XMRV. Science.
48. Sramkoski RM, Pretlow TG, 2nd, Giaconia JM, Pretlow TP, Schwartz S, et al. (1999) A new human prostate carcinoma cell line, 22Rv1. In Vitro Cell Dev Biol Anim 35: 403-409.
49. Pretlow TG, Wolman SR, Micale MA, Pelley RJ, Kursh ED, et al. (1993) Xenografts of primary human prostatic carcinoma. J Natl Cancer Inst 85: 394-398.
50. Nagabhushan M, Miller CM, Pretlow TP, Giaconia JM, Edgehouse NL, et al. (1996) CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. Cancer Res 56: 3042-3046.
51. Knouf EC, Metzger MJ, Mitchell PS, Arroyo JD, Chevillet JR, et al. (2009) Multiple integrated copies and high-level production of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) from 22Rv1 prostate carcinoma cells. J Virol 83: 7353-7356.
52. Groom HC, Yap MW, Galao RP, Neil SJ, Bishop KN, (2010) Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors. Proc Natl Acad Sci U S A 107: 5166-5171.
53. Stieler K, Schulz C, Lavanya M, Aepfelbacher M, Stocking C, et al. (2010) Host range and cellular tropism of the human exogenous gammaretrovirus XMRV. Virology 399: 23-30.
54. Chaipan C, Dilley KA, Paprotka T, Delviks-Frankenberry KA, Venkatachari NJ, et al. (2011) Severe restriction of xenotropic murine leukemia virus-related virus replication and spread in cultured human peripheral blood mononuclear cells. J Virol 85: 4888-4897.
55. Ravichandran V, Major EO, Ibe C, Monaco MC, Girisetty MK, et al. (2011) Susceptibility of human primary neuronal cells to xenotropic murine leukemia virus-related (XMRV) virus infection. Virol J 8: 443.
56. Burtonboy G, Delferriere N, Mousset B, Heusterspreute M, (1993) Isolation of a C-type retrovirus from an HIV infected cell line. Arch Virol 130: 289-300.
57. De Boer EC, Teppema JS, Steerenberg PA, De Jong WH, (2000) Retrovirus type C in the mouse bladder carcinoma cell line MBT-2. J Urol 163: 1999-2001.
58. Deichmann M, Huder JB, Kleist C, Naher H, Schupbach J, et al. (2005) Detection of reverse transcriptase activity in human melanoma cell lines and identification of a murine leukemia virus contaminant. Arch Dermatol Res 296: 345-352.
59. Kotler M, Balabanova H, Ben-Moyal Z, Friedman A, Becker Y, (1977) Properties of the oncornavirus particles isolated from P3HR-1 and Raji human lymphoblastoid cell lines. Isr J Med Sci 13: 740-746.
60. Raisch KP, Kushnaryov VM, Grossberg SE, Cashdollar LW, (1998) Constitutive production of a murine retrovirus in the human B-lymphoblastoid cell line, DG-75. Virology 250: 135-139.
61. Takeuchi Y, McClure MO, Pizzato M, (2008) Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research. J Virol 82: 12585-12588.
62. Yaniv A, Gotlieb-Stematsky T, Vonsover A, Perk K, (1980) Evidence for type-C retrovirus production by Burkitt's lymphoma-derived cell line. Int J Cancer 25: 205-211.
63. Stocking C, Kozak CA, (2008) Murine endogenous retroviruses. Cell Mol Life Sci 65: 3383-3398.
64. Baliji S, Liu Q, Kozak CA, (2010) Common inbred strains of the laboratory mouse that are susceptible to infection by mouse xenotropic gammaretroviruses and the human-derived retrovirus XMRV. J Virol 84: 12841-12849.
65. Kozak CA, Hartley JW, Morse HC, 3rd, (1984) Laboratory and wild-derived mice with multiple loci for production of xenotropic murine leukemia virus. J Virol 51: 77-80.
66. Levy JA, (1999) Xenotropism: the elusive viral receptor finally uncovered. Proc Natl Acad Sci U S A 96: 802-804.
67. Oie HK, Russell EK, Dotson JH, Rhoads JM, Gazdar AF, (1976) Host-range properties of murine xenotropic and ecotropic type-C viruses. J Natl Cancer Inst 56: 423-426.
68. Achong BG, Trumper PA, Giovanella BC, (1976) C-type virus particles in human tumours transplanted into nude mice. Br J Cancer 34: 203-206.
69. Gautsch JW, Knowles AF, Jensen FC, Kaplan NO, (1980) Highly efficient induction of type C retroviruses by a human tumor in athymic mice. Proc Natl Acad Sci U S A 77: 2247-2250.
70. Suzuki T, Yanagihara K, Yoshida K, Seido T, Kuga N, (1977) Infectious murine type-C viruses released from human cancer cells transplated into nude mice. Gann 68: 99-106.
71. Todaro GJ, Arnstein P, Parks WP, Lennette EH, Huebner RJ, (1973) A type-C virus in human rhabdomyosarcoma cells after inoculation into NIH Swiss mice treated with antithymocyte serum. Proc Natl Acad Sci U S A 70: 859-862.
72. Zhang YA, Maitra A, Hsieh JT, Rudin CM, Peacock C, et al. (2011) Frequent detection of infectious xenotropic murine leukemia virus (XMLV) in human cultures established from mouse xenografts. Cancer Biol Ther 12: 617-628.
73. Sfanos KS, Aloia AL, Hicks JL, Esopi DM, Steranka JP, et al. (2011) Identification of replication competent murine gammaretroviruses in commonly used prostate cancer cell lines. PLoS One 6: e20874.
74. Chiu YL, Greene WC, (2008) The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu Rev Immunol 26: 317-353.
75. Stopak K, de Noronha C, Yonemoto W, Greene WC, (2003) HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol Cell 12: 591-601.
76. Wiegand HL, Doehle BP, Bogerd HP, Cullen BR, (2004) A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins. EMBO J 23: 2451-2458.
77. Rulli SJ Jr, Mirro J, Hill SA, Lloyd P, Gorelick RJ, et al. (2008) Interactions of murine APOBEC3 and human APOBEC3G with murine leukemia viruses. J Virol 82: 6566-6575.
78. Sheehy AM, Gaddis NC, Choi JD, Malim MH, (2002) Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418: 646-650.
79. Dutko JA, Schafer A, Kenny AE, Cullen BR, Curcio MJ, (2005) Inhibition of a yeast LTR retrotransposon by human APOBEC3 cytidine deaminases. Curr Biol 15: 661-666.
80. Esnault C, Heidmann O, Delebecque F, Dewannieux M, Ribet D, et al. (2005) APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. Nature 433: 430-433.
81. Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, et al. (2003) DNA deamination mediates innate immunity to retroviral infection. Cell 113: 803-809.
82. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, et al. (2003) Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424: 99-103.
83. Paprotka T, Venkatachari NJ, Chaipan C, Burdick R, Delviks-Frankenberry KA, et al. (2010) Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs. J Virol 84: 5719-5729.
84. Stieler K, Fischer N, (2010) Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV. PLoS One 5: e11738.
85. Bogerd HP, Zhang F, Bieniasz PD, Cullen BR, (2011) Human APOBEC3 proteins can inhibit xenotropic murine leukemia virus-related virus infectivity. Virology 410: 234-239.
86. Onlamoon N, Das Gupta J, Sharma P, Rogers K, Suppiah S, et al. (2011) Infection, viral dissemination, and antibody responses of rhesus macaques exposed to the human gammaretrovirus XMRV. J Virol 85: 4547-4557.
87. Del Prete GQ, Kearney MF, Spindler J, Wiegand A, Chertova E, et al. (2012) Restricted Replication of Xenotropic Murine Leukemia Virus-Related Virus in Pigtailed Macaques. J Virol 86: 3152-3166.
88. Glushakova S, Baibakov B, Margolis LB, Zimmerberg J, (1995) Infection of human tonsil histocultures: a model for HIV pathogenesis. Nat Med 1: 1320-1322.
89. Glushakova S, Baibakov B, Zimmerberg J, Margolis LB, (1997) Experimental HIV infection of human lymphoid tissue: correlation of CD4+ T cell depletion and virus syncytium-inducing/non-syncytium-inducing phenotype in histocultures inoculated with laboratory strains and patient isolates of HIV type 1. AIDS Res Hum Retroviruses 13: 461-471.
90. Grivel JC, Santoro F, Chen S, Faga G, Malnati MS, et al. (2003) Pathogenic effects of human herpesvirus 6 in human lymphoid tissue ex vivo. J Virol 77: 8280-8289.
91. Rose PP, Korber BT, (2000) Detecting hypermutations in viral sequences with an emphasis on G→A hypermutation. Bioinformatics 16: 400-401.
92. Singh IR, Gorzynski JE, Drobysheva D, Bassit L, Schinazi RF, (2010) Raltegravir is a potent inhibitor of XMRV, a virus implicated in prostate cancer and chronic fatigue syndrome. PLoS One 5: e9948.
93. Sakuma R, Sakuma T, Ohmine S, Silverman RH, Ikeda Y, (2010) Xenotropic murine leukemia virus-related virus is susceptible to AZT. Virology 397: 1-6.
94. Hazuda DJ, Felock P, Witmer M, Wolfe A, Stillmock K, et al. (2000) Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. Science 287: 646-650.
95. Koning FA, Newman EN, Kim EY, Kunstman KJ, Wolinsky SM, et al. (2009) Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J Virol 83: 9474-9485.
96. Grivel JC, Biancotto A, Ito Y, Lima RG, Margolis LB, (2003) Bystander CD4+ T lymphocytes survive in HIV-infected human lymphoid tissue. AIDS Res Hum Retroviruses 19: 211-216.
97. Grivel JC, Elliott J, Lisco A, Biancotto A, Condack C, et al. (2007) HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1. AIDS 21: 1263-1272.
98. Ito Y, Grivel JC, Chen S, Kiselyeva Y, Reichelderfer P, et al. (2004) CXCR4-tropic HIV-1 suppresses replication of CCR5-tropic HIV-1 in human lymphoid tissue by selective induction of CC-chemokines. J Infect Dis 189: 506-514.
99. Lombardi VC, Hagen KS, Hunter KW, Diamond JW, Smith-Gagen J, et al. (2011) Xenotropic Murine Leukemia Virus-related Virus-associated Chronic Fatigue Syndrome Reveals a Distinct Inflammatory Signature. In Vivo 25: 307-314.
100. Brenu EW, van Driel ML, Staines DR, Ashton KJ, Ramos SB, et al. (2011) Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. J Transl Med 9: 81.
101. Battini JL, Rasko JE, Miller AD, (1999) A human cell-surface receptor for xenotropic and polytropic murine leukemia viruses: possible role in G protein-coupled signal transduction. Proc Natl Acad Sci U S A 96: 1385-1390.
102. Rodriguez JJ, Goff SP, (2010) Xenotropic murine leukemia virus-related virus establishes an efficient spreading infection and exhibits enhanced transcriptional activity in prostate carcinoma cells. J Virol 84: 2556-2562.
103. Zhao C, Papadopoulou B, Tremblay MJ, (2004) Leishmania infantum promotes replication of HIV type 1 in human lymphoid tissue cultured ex vivo by inducing secretion of the proinflammatory cytokines TNF-alpha and IL-1 alpha. J Immunol 172: 3086-3093.